US Bancorp
PLXP

US Bancorp’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

US Bancorp’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-506
Closed -$40K – 3647
2016
Q2 		$40K Hold
506
– – ﹤0.01% 2515
2016
Q1 		$38K Hold
506
– – ﹤0.01% 2516
2015
Q4 		$45K Hold
506
– – ﹤0.01% 2496
2015
Q3 		$57K Buy
+506
New +$58.2K ﹤0.01% 2394

Other funds holding PLXP

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSVM
Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
EA
Emerald Acquisition Seattle, Washington $51.8B AUM
TCM
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

US Bancorp's PLXP Position: Q3 2016 in Review

US Bancorp sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2016, closing a stake of 506 shares — an estimated $40K sold.

US Bancorp first reported a position in PLXP in Q3 2015 and held it in 4 quarters. The position peaked at $57K in Q3 2015. 32 funds tracked by Wall St. Rank hold PLXP as of Q3 2016.

  • US Bancorp reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • US Bancorp sold 506 PLx Pharma Inc. Common Stock shares in Q3 2016, an estimated $40K.
  • US Bancorp first reported a position in PLx Pharma Inc. Common Stock in Q3 2015 and held it in 4 quarters.
  • US Bancorp's PLx Pharma Inc. Common Stock position peaked at $57K in Q3 2015.
  • 32 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2016.

Based on US Bancorp's 13F filing for Q3 2016, filed 4 Nov 2016.